Theracryf Plc (AIM:TCF)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 0.1718
+0.0018 (1.06%)
Nov 6, 2026, 12:08 PM GMT
Theracryf Market Cap
Theracryf has a market cap or net worth of 4.69 million as of November 6, 2026. It is the 43,768th most valuable company in the world and the 986th biggest in the United Kingdom. Its market cap has increased by 4.96% in one year.
Market Cap
4.69M
Enterprise Value
3.16M
Revenue
n/a
Global Rank
Country Rank
#986 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since October 21, 2015, Theracryf's market cap has decreased from 25.60M to 4.69M, a decrease of -81.66%. That is a compound annual growth rate of -14.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 4.64M | 8.07% |
| Dec 31, 2025 | 4.30M | 90.55% |
| Dec 31, 2024 | 2.26M | -48.72% |
| Dec 29, 2023 | 4.40M | -64.04% |
| Dec 30, 2022 | 12.23M | -13.59% |
| Dec 31, 2021 | 14.16M | -0.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Thalia Therapeutics | 9.78M |
| Aptamer Group | 9.37M |
| Palatin Technologies | 7.26M |
| Fusion Antibodies | 7.26M |
| CRISM Therapeutics | 6.73M |
| Solvonis Therapeutics | 6.30M |
| OptiBiotix Health | 5.68M |
| Cizzle Biotechnology Holdings | 4.76M |